Therapeutic developments in peroxisome biogenesis disorders

Author： McGuinness M.C. Wei H. Smith K.D.

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.9, Iss.9, 2000-09, pp. : 1985-1992

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mitochondrial Biogenesis: A Therapeutic Target for Neurodevelopmental Disorders and Neurodegenerative Diseases

Current Pharmaceutical Design, Vol. 20, Iss. 35, 2014-10 ,pp. : 5574-5593

Bentham Science Publishers

Access to resources Recommend Favorite

Peroxisome Proliferator-Activated Receptor (PPAR) Gamma Agonists as Therapeutic Agents for Cardiovascular Disorders: Focus on Atherosclerosis

Current Pharmaceutical Design, Vol. 23, Iss. 7, 2017-04 ,pp. : 1119-1124

Bentham Science Publishers

Access to resources Recommend Favorite

Mitochondrial Biogenesis in Health and Disease. Molecular and Therapeutic Approaches

Current Pharmaceutical Design, Vol. 20, Iss. 35, 2014-10 ,pp. : 5619-5633

Bentham Science Publishers

Access to resources Recommend Favorite

Pazopanib: therapeutic developments

By Limvorasak Suwicha Posadas Edwin M

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 18, 2009-12 ,pp. : 3091-3102

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic developments in cytomegalovirus retinitis

By Hoffman V.F. Skiest D.J.

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 2, 2000-02 ,pp. : 207-220

Informa Healthcare

Access to resources Recommend Favorite